<Disease><Name>PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY (PNP)</Name><Synonym>NUCLEOSIDE PHOSPHORYLASE; IMMUNODEFICIENCY</Synonym><OMIM><Number>613179</Number><URL>http://omim.org/entry/613179</URL></OMIM><Orphanet><Number>760</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=760</URL></Orphanet><Protein><Number>purine nucleoside phosphorylase</Number><URL>http://www.uniprot.org/uniprot/P00491</URL></Protein><ExPASy><Number>2.4.2.1</Number><URL>http://enzyme.expasy.org/EC/2.4.2.1</URL></ExPASy><Gene>14q13.1</Gene><ICD>D81.5</ICD><Summary>rare ;autosomal recessive;mutation in the PNP gene</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>2275</id><symptom>infections (urinary tract)</symptom><category>GENITOURINARY TRACT | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>3243</id><symptom>lymphopenia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2038</id><symptom>neutropenia (decreased neutrophils)</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2273</id><symptom>pneumonia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2263</id><symptom>strokelike episodes</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1836</id><name>Inosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1838</id><name>Orotic acid</name><specimen>urine</specimen><value>normal/inc</value><min>5.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>2075</id><name>Guanosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>2087</id><name>2-Deoxyuridine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>2088</id><name>2-Deoxyuridine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>1.70</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>2000</id><name>2-Deoxyguanosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>2017</id><name>Guanosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1402</id><name>Inosine</name><specimen /><value>increased</value><min>    </min><max>    </max><unit /><age /><method /><comment /></metabolite><metabolite><id>1628</id><name>Inosine</name><specimen>urine</specimen><value>increased</value><min>0.40</min><max>6.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>18</id><name>Orotic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>11.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>1530</id><name>Orotic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.35</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>1369</id><name>Orotic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>804</id><name>Orotic acid</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>0.50</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1153</id><name>Orotic acid</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit /><age>child</age><method /><comment /></metabolite><metabolite><id>451</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>527.00</min><max>790.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1535</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>222.00</min><max>287.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>776</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>820.00</min><max>1026.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>417</id><name>Uric acid</name><specimen>serum</specimen><value>decreased</value><min>120.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7068</id><title>The First Purine Nucleoside Phosphorylase Deficiency Patient Resembling IgA Deficiency and a Review of the Literature</title><author>Fekrvand S,</author><journal>Immunol Invest</journal><year>2019</year><book /><volume>48</volume><number>4</number><pages>410-430</pages><co_aut>et al.</co_aut></literature><literature><id>4917</id><title>Infusion of Sibling Marrow in a Patient with Purine Nucleoside Phosphorylase Deficiency Leads to Split Mixed Donor Chimerism and Normal Immunity</title><author>Yeates L,</author><journal>Front Pediatr</journal><year>2017</year><book /><volume>5</volume><number>0</number><pages>143</pages><co_aut>Slatter MA, Gennery AR</co_aut></literature><literature><id>4918</id><title>Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during </title><author>la Marca G,</author><journal>Clin Chem Lab Med</journal><year>2016</year><book /><volume>54</volume><number>4</number><pages>627-632</pages><co_aut>et al.</co_aut></literature><literature><id>4919</id><title>The First Report of a Pregnancy in a Patient with Purine Nucleoside Phosphorylase Deficiency</title><author>Martin J,</author><journal>Fetal Pediatr Pathol</journal><year>2016</year><book /><volume>35</volume><number>2</number><pages>120-123</pages><co_aut>et al.</co_aut></literature><literature><id>4920</id><title>Purine nucleoside phosphorylase deficiency: a mutation update</title><author>Walker PL,</author><journal>Nucleosides Nucleotides Nucleic Acids</journal><year>2011</year><book /><volume>30</volume><number>12</number><pages>1243-1247</pages><co_aut>et al.</co_aut></literature><literature><id>2106</id><title>Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology</title><author>Dror Y</author><journal>Pediatr Res</journal><year>2004</year><book /><volume>55</volume><number>3</number><pages>472-477</pages><co_aut>et al.</co_aut></literature><literature><id>2107</id><title>Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction</title><author>Myers LA</author><journal>J Pediatr</journal><year>2004</year><book /><volume>145</volume><number>5</number><pages>710-712</pages><co_aut>et al.</co_aut></literature><literature><id>2108</id><title>Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency</title><author>Baguette C</author><journal>J Pediatr Hematol Oncol</journal><year>2002</year><book /><volume>24</volume><number>1</number><pages>69-71</pages><co_aut>et al.</co_aut></literature><literature><id>771</id><title>Disorders of purine and pyrimidine metabolism</title><author>van den Berghe G</author><journal>in Fernandes J, Saudubray JM, van den Berghe (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>289-302</pages><co_aut>Vincent MF</co_aut></literature><literature><id>2109</id><title>Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling</title><author>Broome CB</author><journal>J Pediatr</journal><year>1996</year><book /><volume>128</volume><number>3</number><pages>373-376</pages><co_aut>et al.</co_aut></literature><literature><id>5969</id><title>Urinary excretion of orotic acid, orotidine and other pyrimidines in a patient with purine nucleoside phosphorylase deficiency</title><author>van Gennip AH,</author><journal>Clin Chim Acta</journal><year>1979</year><book /><volume>93</volume><number>3</number><pages>419-428</pages><co_aut>et al.</co_aut></literature><literature><id>3198</id><title>Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases</title><author>Blau N</author><journal>Springer</journal><year>0</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3199</id><title>Handbook of 1H-NMR spectroscopy in inborn errors of metabolism: body fluid NMR spectroscopy and in vivo MR spectroscopy</title><author>Engelke UFH</author><journal>SPS</journal><year>0</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Wevers RA</co_aut></literature></Literatures></Disease>